Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSV and Influenza Human Challenge
NCT02755948Completed
- Sponsor
- Imperial College London
- Start
- Apr 2012
- Primary completion
- Feb 2020
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Imperial College London. Primary endpoint: Total Symptom Score at 14 days. Started Apr 2012; status: completed.
Beyond the preview
Go deeper on NCT02755948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755948.